STAT News

STAT+: AstraZeneca invests $2 billion in Summit Therapeutics

AstraZeneca is teaming up with Summit Therapeutics to test its PD-1/VEGF bispecific ivonescimab alongside AstraZeneca’s antibody-drug conjugates.

作者 STAT News

1 分钟阅读
STAT+: AstraZeneca invests $2 billion in Summit Therapeutics
STAT+: AstraZeneca invests $2 billion in Summit Therapeutics

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

相关洞察